SPI

SPI handeln
18.636,58 PKT -189,93 PKT -1,01 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 998750

ISIN CH0009987501


Analysen zu SPI-Werten

Datum Rating Analyst
06.11.12 Holcim hold Société Générale Group S.A. (SG)
06.11.12 Avolta (ex Dufry) buy Vontobel Research
06.11.12 Burckhardt Compression hold Vontobel Research
06.11.12 Partners Group buy Sarasin Research
06.11.12 dormakaba hold Vontobel Research
06.11.12 Adecco SA buy Sarasin Research
06.11.12 Adecco SA buy Vontobel Research
05.11.12 Swiss Re sell Goldman Sachs Group Inc.
05.11.12 Novartis neutral Citigroup Corp.
05.11.12 Roche neutral Citigroup Corp.
05.11.12 Holcim buy Société Générale Group S.A. (SG)
05.11.12 Partners Group hold Vontobel Research
05.11.12 Partners Group neutral Sarasin Research
05.11.12 Avolta (ex Dufry) buy Vontobel Research
05.11.12 Avolta (ex Dufry) neutral Sarasin Research
05.11.12 Calida hold Vontobel Research
05.11.12 UBS buy Citigroup Corp.
06.11.12 Novartis outperform Exane-BNP Paribas SA
02.11.12 Swiss Re buy Société Générale Group S.A. (SG)
02.11.12 UBS hold Société Générale Group S.A. (SG)
02.11.12 UBS buy Société Générale Group S.A. (SG)
02.11.12 Ypsomed hold Vontobel Research
02.11.12 Geberit hold Vontobel Research
02.11.12 Burckhardt Compression hold Vontobel Research
01.11.12 UBS buy Nomura
01.11.12 Avolta (ex Dufry) outperform Exane-BNP Paribas SA
01.11.12 Clariant sell Société Générale Group S.A. (SG)
01.11.12 Straumann underperform Exane-BNP Paribas SA
01.11.12 Lonza hold Vontobel Research
01.11.12 DKSH hold Vontobel Research
01.11.12 Schindler hold Vontobel Research
01.11.12 Ypsomed hold Vontobel Research
01.11.12 Rieter buy Vontobel Research
01.11.12 Sika hold Vontobel Research
01.11.12 Clariant buy Vontobel Research
01.11.12 Swisscom hold Vontobel Research
01.11.12 UBS halten Independent Research GmbH
01.11.12 UBS buy Sarasin Research
01.11.12 Swisscom neutral Sarasin Research
31.10.12 UBS outperform Exane-BNP Paribas SA